Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in albumin microspheres

Drug Testing and Analysis

Volumn 5, Issue 6, 2013, Pages 453-460

  Khan, Wahid ^a   Sharma, Shyam S ^b   Kumar, Neeraj ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b NIPER   (India)

Author keywords

Albumin microspheres; Bioanalytical method; Paromomycin; Pharmacokinetics; Toxicity studies

Indexed keywords

BLOOD; MACROPHAGES; METABOLISM; PHARMACOKINETICS; TOXICITY; UREA;

ALBUMIN MICROSPHERE; BIOANALYTICAL METHODS; HOST DEFENSE; INTRAMUSCULAR INJECTIONS; LEISHMANIA; METHOD DEVELOPMENT; PARASITE-; PAROMOMYCIN; PHARMACOKINETIC STUDIES; TOXICITY STUDY;

MICROSPHERES;

9 FLUORENYLMETHYL CHLOROFORMATE; ALBUMIN MICROSPHERE; PAROMOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG SCREENING; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; TOXICITY TESTING; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS;

EID: 84879030132     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.339     Document Type: Article

References (28)

1. T.R. Zembower, G.A. Noskin, M.J. Postelnick, C. Nguyen, L.R. Peterson The utility of aminoglycosides in an era of emerging drug resistance. Int. J. Antimicrob. Ag. 1998, 10, 95.
2. C. Leandro, L. Campino Leishmaniasis: efflux pumps and chemoresistance. Int. J. Antimicrob. Ag. 2003, 22, 352.
3. M. Ouellette, J. Drummelsmith, B. Papadopoulou Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist. Update 2004, 7, 257.
4. S. Sundar, M. Chatterjee Visceral leishmaniasis-current therapeutic modalities. Indian J. Med. Res. 2006, 123, 345.
5. S. Sundar, T.K. Jha, C.P. Thakur, P.K. Sinha, S.K. Bhattacharya Injectable paromomycin for visceral leishmaniasis in India. New Engl. J. Med. 2007, 356, 2571.
6. M.R. Jaafari, N. Bavarsad, B.S. Bazzaz, A. Samiei, D. Soroush, S. Ghorbani, et al. Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice. Antimicrob. Agents Ch. 2009, 53, 2259.
7. S.L. Croft, V. Yardley Chemotherapy of leishmaniasis. Curr. Pharm. Design 2002, 8, 319.
8. C.P. Thakur Tetany in kala azar patients treated with paromomycin. Indian J. Med. Res. 2008, 127, 489.
9. W. Khan, N. Kumar Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation. J. Drug Target. 2011, 19, 239.
10. L. Ordonez-Gutierrez, R. Espada-Fernandez, M.A. Dea-Ayuela, J.J. Torrado, F. Bolas-Fernandez, J.M. Alunda In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum. Int. J. Antimicrob. Ag. 2007, 30, 325.
11. J.A. Sanchez-Brunete, M.A. Dea, S. Rama, F. Bolas, J.M. Alunda, R. Raposo, et al. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres. Antimicrob. Agents Ch. 2004, 48, 3246.
12. W. Khan, N. Kumar Characterization, thermal stability studies, and analytical method development of Paromomycin for formulation development. Drug Test. Analysis 2011, 3, 363.
13. Z. Liu, Y. Sha, T. Huang, B. Yang, G.L. Duan High-performance liquid chromatographic determination of vertilmicin in rat plasma using sensitive fluorometric derivatization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 828, 2.
14. K. Rona, G. Klausz, E. Keller, M. Szakay, P. Laczay, M. Shem-Tov, et al. Determination of paromomycin residues in turkey tissues by liquid chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3792.
15. D.K. Haswani, H. Nettey, C. Oettinger, M.J. D'Souza Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J. Microencapsul. 2006, 23, 875.
16. H. Nettey, D. Haswani, C.W. Oettinger, M.J. D'Souza Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. J. Microencapsul. 2006, 23, 632.
17. A. Watanabe, J. Nagai, Y. Adachi, T. Katsube, Y. Kitahara, T. Murakami, et al. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists. J. Control. Release 2004, 95, 423.
18. J. Fierer, L. Hatlen, J.P. Lin, D. Estrella, P. Mihalko, A. Yau-Young Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice. Antimicrob. Agents Ch. 1990, 34, 343.
19. M.M. Sayed-Ahmed, M.N. Nagi Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clin. Exp. Pharmacol. Physiol. 2007, 34, 399.
20. T.P. Kanyok, A.D. Killian, K.A. Rodvold, L.H. Danziger Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects. Antimicrob. Agents Chemother. 1997, 41, 982.
21. L. Monzote Current treatment of leishmaniasis: A review. The Open Antimicrobial Agents Journal 2009, 1, 9.
22. F. Chellat, Y. Merhi, A. Moreau, L. Yahia Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005, 26, 7260.
23. U. Scheffel, B.A. Rhodes, T.K. Natarajan, H.N. Wagner, Jr. Albumin microspheres for study of the reticuloendothelial system. J. Nucl. Med. 1972, 13, 498.
24. J. Lu, M. Cwik, T. Kanyok Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2, 4-dinitrofluorobenzene derivatization. J. Chromatogr. B 1997, 695, 329.
25. R. Oertel, V. Neumeister, W. Kirch Hydrophilic interaction chromatography combined with tandem-mass spectrometry to determine six aminoglycosides in serum. J. Chromatogr. A 2004, 1058, 197.
26. L.S. Ferreira, G.A. Ramaldes, E.A. Nunan, L.A. Ferreira In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis. Drug Dev. Ind. Pharm. 2004, 30, 289.
27. M.G. Aguiar, D.L. Silva, F.A. Nunan, E.A. Nunan, A.P. Fernandes, L.A. Ferreira Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens. J. Antimicrob. Chemoth. 2009, 64, 1234.
28. G.N. Shankar, H.J. Parish Orally-absorbed formulation for paromomycin. US 2008/0207745 A1. 2008, 1-7.